Rehago is a software-based medical device designed to help hemiplegic patients return to a self-determined life more quickly. Previous experiences with paper-based studies brought delays as well as transmission errors, which is why Rehago now counts on Climedo for clinical data capture. The software enables real-time monitoring of study status, enhanced data quality, as well as time and cost savings. In addition, Climedo helps to implement a multi-center study at several clinics, while maintaining a clear overview and all data in one place.
Prof. Dr. Christoph Schmitz
Chief Medical Officer, Auto Tissue Berlin
Christiane Weis, M.Sc.
Clinical Department, GELITA MEDICAL GmbH
Dr. Jens Milde
Managing Director, Pharmalog
Dr. med. dent. Wolfgang Maas
Oral Surgeon, Implantology Practice
Dr. med. Lena Oevermann
Med. specialist for paediatric haematology and oncology, Charité Berlin